The impact of the new Global Lung Function Initiative TLCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis

Monique Wapenaar, Jelle R. Miedema, Catharina J. Lammering, Frans W. Mertens, Marlies S. Wijsenbeek

Source: Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018
Journal Issue: February
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Monique Wapenaar, Jelle R. Miedema, Catharina J. Lammering, Frans W. Mertens, Marlies S. Wijsenbeek. The impact of the new Global Lung Function Initiative TLCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis. Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: